(Q38168479)

30 August 2017

Evaluation of dabigatran exposures reported to poison control centers (English)

1 reference

30 August 2017

1 reference

Susan E Conway

1

1 reference

30 August 2017

Scott E Schaeffer

series ordinal

2

1 reference

30 August 2017

Donald L Harrison

series ordinal

3

1 reference

30 August 2017

language of work or name

English

0 references

publication date

3 December 2013

1 reference

Annals of Pharmacotherapy

30 August 2017

1 reference

30 August 2017

48

1 reference

30 August 2017

354-360

1 reference

30 August 2017

3

1 reference

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

30 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Clinical pharmacology basis of deriving dosing recommendations for dabigatran in patients with severe renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

In reply to 'Dabigatran pharmacokinetics--implications for treatment'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Safe use of hemodialysis for dabigatran removal before cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: guideline methodology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Atrial fibrillation: current knowledge and future directions in epidemiology and genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Validation of Clinical Classification Schemes for Predicting Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Current state of knowledge on oral anticoagulant reversal using procoagulant factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Consistency between coded poison center data and fatality abstract narratives for therapeutic error deaths in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

Hemopericardium in a patient treated with dabigatran etexilate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013513883

21 January 2018

Identifiers

DOI

10.1177/1060028013513883

1 reference

30 August 2017

1 reference